Trocar-site incisional hernia after laparoscopic colorectal surgery: a significant problem? Incidence and risk factors from a single-center cohort

Author(s):  
Oscar Cano-Valderrama ◽  
Rodrigo Sanz-López ◽  
Gonzalo Sanz-Ortega ◽  
Rocío Anula ◽  
José L. Romera ◽  
...  
2018 ◽  
Vol 11 (4) ◽  
pp. 373-377 ◽  
Author(s):  
Masateru Yamamoto ◽  
Yuji Takakura ◽  
Satoshi Ikeda ◽  
Toshiyuki Itamoto ◽  
Takashi Urushihara ◽  
...  

2004 ◽  
Vol 47 (10) ◽  
pp. 1686-1693 ◽  
Author(s):  
Andrea Vignali ◽  
Marco Braga ◽  
Walter Zuliani ◽  
Matteo Frasson ◽  
Giovanni Radaelli ◽  
...  

2020 ◽  
Author(s):  
Xueyan Li ◽  
Genshan Ma ◽  
Xiaobo Qian ◽  
Yamou Wu ◽  
Xiaochen Huang ◽  
...  

Abstract Background: We aimed to assess the performance of machine learning algorithms for the prediction of risk factors of postoperative ileus (POI) in patients underwent laparoscopic colorectal surgery for malignant lesions. Methods: We conducted analyses in a retrospective observational study with a total of 637 patients at Suzhou Hospital of Nanjing Medical University. Four machine learning algorithms (logistic regression, decision tree, random forest, gradient boosting decision tree) were considered to predict risk factors of POI. The total cases were randomly divided into training and testing data sets, with a ratio of 8:2. The performance of each model was evaluated by area under receiver operator characteristic curve (AUC), precision, recall and F1-score. Results: The morbidity of POI in this study was 19.15% (122/637). Gradient boosting decision tree reached the highest AUC (0.76) and was the best model for POI risk prediction. In addition, the results of the importance matrix of gradient boosting decision tree showed that the five most important variables were time to first passage of flatus, opioids during POD3, duration of surgery, height and weight. Conclusions: The gradient boosting decision tree was the optimal model to predict the risk of POI in patients underwent laparoscopic colorectal surgery for malignant lesions. And the results of our study could be useful for clinical guidelines in POI risk prediction.


2019 ◽  
Vol 34 (9) ◽  
pp. 4048-4052 ◽  
Author(s):  
Oscar Cano-Valderrama ◽  
Rodrigo Sanz-López ◽  
Inmaculada Domínguez-Serrano ◽  
Jana Dziakova ◽  
Vanesa Catalán ◽  
...  

BMC Surgery ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Ana Ciscar ◽  
Josep M. Badia ◽  
Francesc Novell ◽  
Santiago Bolívar ◽  
Esther Mans

Abstract Background Trocar site incisional hernia (TSIH) is the most frequent complication associated with laparoscopic surgery. Few studies currently describe its incidence or risk factors. The aim of this report is to determine the real incidence of TSIH and to identify risk factors. Methods A cross-sectional prospective study was performed including consecutive patients who underwent a laparoscopic procedure during a 4 months period. All the patients were assessed both clinically (TSIHc) and by an ultrasonographic examination (TSIHu). The main variable studied was the incidence of TSIH. A multivariate analysis was performed to identify risk factors. Results 76 patients were included. 27.6% of patients were clinically diagnosed as having TSIH (TSIHc) but only 23.7% of those cases were radiologically confirmed (TSIHu). In the logistic regression analysis, age > 70 years (OR 3.462 CI 1.14–10.515, p = 0.028) and body mass index (BMI) ≥ 30 kg/m2 (OR 3.313 CI 1.037–10.588, p = 0.043) were identified as risk factors for TSIH. The size of the trocar also showed statistically significant differences (p < 0.001). Mean follow-up time was 34 months. Conclusions TSIH is under-diagnosed due to the lack of related symptomatology and the inadequacy of the postoperative follow-up period. We detected discrepancies between the clinical and ultrasonographic examinations. TSIHu should be considered as the gold standard for the diagnosis of TSIH. Risk factors such as age, BMI and size of the trocar were confirmed. Patients should be followed-up for a minimum of 2 years. Trial registration The study has been retrospectively registered in Clinicaltrials.gov on June 4, 2020 under registration number: NCT04410744


2013 ◽  
Vol 27 (12) ◽  
pp. 4574-4580 ◽  
Author(s):  
Joseph Drosdeck ◽  
Alan Harzman ◽  
Andrew Suzo ◽  
Mark Arnold ◽  
Mahmoud Abdel-Rasoul ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document